Skip to main content

Table 1 Sample characteristics at baseline by adherence status

From: Effectiveness of a prevention program in the incidence of cardiovascular outcomes in a low-income population from Colombia: a real-world propensity score-matched cohort study

Characteristic

Unmatcheda

Matcheda

Adherent

Non-adherent

SMD

Adherent

Non-adherent

SMD

Frequency of patients, n (%)

20,613

31,894

 

19,943

15,631

 

Sex

 Female

13,914 (67.5)

19,983 (62.7)

0.103

13,464 (67.5)

10,351 (66.2)

0.032

 Male

6699 (32.5)

11,911 (37.3)

0.103

6479 (32.5)

5280 (33.8)

0.032

Age in years, mean (SD)

56.1 (10.2)

56.4 (10.4)

0.034

56.1 (10.2)

56.2 (10.4)

0.011

Overweight or obesity (BMI > 25)

13,356 (64.9)

21,023 (66)

0.024

13,001 (65.2)

10,337 (66.1)

0.004

Diagnosis at baseline

 Hypertension

19,796 (96)

30,010 (94.1)

0.1

19,179 (96.2)

14,904 (95.3)

0.074

 Diabetes millitus type 2

4224 (20.5)

10,983 (34.4)

0.345

4061 (20.4)

4033 (25.8)

0.135

 Dyslipidemia

4759 (23.1)

13,962 (43.8)

0.491

4681 (23.5)

5084 (32.5)

0.075

 Chronic kidney disease

2326 (11.3)

3226 (10.1)

0.037

2252 (11.3)

1560 (10)

0.003

Prevalence groups

 HTA

10,733 (52.1)

9074 (28.5)

0.473

10,353 (51.9)

6542 (41.9)

0.038

 HTA + Dyslipidemia

3665 (17.8)

9329 (29.3)

0.3

3603 (18.1)

3782 (24.2)

0.086

 HTA + DM

2432 (11.8)

5037 (15.8)

0.124

2340 (11.7)

2202 (14.1)

0.102

 HTA + DM + Dyslipidemia

1582 (7.7)

1432 (4.5)

0.12

1523 (7.6)

864 (5.5)

0.015

 HTA + CKD

817 (4.0)

1884 (5.9)

0.1

764 (3.8)

727 (4.7)

0.074

 DM

640 (3.1)

3344 (10.5)

0.425

631 (3.2)

818 (5.2)

0.034

 HTA + CKD + Dyslipidemia

409 (2.0)

1076 (3.4)

0.1

403 (2.0)

410 (2.6)

0.044

 HTA + DM + CKD

290 (1.4)

505 (1.6)

0.015

282 (1.4)

212 (1.4)

0.002

 HTA + DM + Dyslipidemia + CKD

45 (0.2)

213 (0.7)

0.096

44 (0.2)

74 (0.5)

0.036

Cardiovascular risk factors, mean (SD)

 Systolic blood pressure (mmHg)

127.1 (14.9)

129.1 (17.2)

0.134

127.1 (14.9)

128.2 (16.3)

0.07

 Diastolic blood pressure (mmHg)

80.2 (11)

81.5 (12.1)

0.12

80.3 (11)

81 (12.2)

0.054

 Glycated hemoglobin (HbA1c)

6.9 (1.8)

8.4 (2.4)

0.801

6.9 (1.7)

7.2 (1.7)

0.036

 Total cholesterol (mg/dl)

190.5 (40.9)

201.2 (44.1)

0.263

190.2 (40.4)

194.1 (41.4)

0.019

 LDL cholesterol (mg/dl)

109.7 (32.8)

117.8 (33.3)

0.247

109.8 (32.8)

113.1 (31.7)

0.016

 HDL cholesterol (mg/dl)

47.7 (11.1)

47.6 (10.9)

0.011

47.7 (11.1)

47.6 (11)

0.018

 Triglycerides (mg/dl)

153.1 (72.4)

169.6 (79.4)

0.229

152.3 (71.3)

159.6 (72.2)

0.045

 Current smokingb

1075 (5.2)

8525 (26.7)

0.968

1050 (5.3)

1384 (8.9)

0.006

Frequency of physical activity

  Never

9172 (44.5)

25,381 (79.6)

0.706

9050 (45.4)

11,196 (71.6)

0.024

  Occasional

7396 (35.9)

4350 (13.6)

0.464

7098 (35.6)

2868 (18.3)

0.049

  Frequent

4045 (19.6)

2163 (6.8)

0.323

3795 (19.0)

1567 (10.0)

0.029

  1. aThe overall matched and unmatched samples equal to the sum of the marched and unmatched patients within each risk group. bA patient was considered a current smoker if reported to be a smoker or ex-smoker during the last year in the program. BMI Body Mass Index, LDL Low-density lipoprotein cholesterol, HDL High density lipoprotein cholesterol, HTA Hypertension, DM Diabetes Mellitus, SMD Absolute Standardized Mean Difference